Raun K, Fels JJ, Rosenquist C, et al
As a selenoprotein, GPX4 catalyzes the reduction of lipid hydroperoxides, establishing its enzymatic centrality in ferroptosis regulation (59)
Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial [press release]
This concept is early and speculative, but it highlights a promising direction for future research, especially for patients who struggle with inadequate response to current hormonal treatments
-Inhibit tyrosinase activity & eumelanin synthesis to prevent dark pigmentations
Estrogen plays a critical role in supporting insulin sensitivity, glucose metabolism, and healthy weight balance